MTOR and Kaposi's sarcoma: mTOR inhibition has been shown to reduce PEL cell survival by interfering with the release of cytokines known to be essential for PEL cell growth, and more recently it has been shown that mTOR inhibition can be effective also against a second KSHV-associated malignancy such as Kaposi's sarcoma.